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INTRODUCTION
The aim of reconstructive surgery is the restoration of shape
and function of the tissue lost due to trauma, oncological
surgery, congenital defect, burns and infection. Free flap
surgery has become a fundamental part of reconstructive
surgery; the technique involves separation of the tissue flap
from its original vascular supply and microvascular reanas-
tomosis of the pedicle artery and vein at a recipient site. The
first free tissue transfer was performed in 1972, using a free
omental flap for scalp defect reconstruction (McLean and
Buncke, 1972). Early flap failure rates reached 40 to 50 per
cent. Later the techniques for microvascular tissue transfer
steadily evolved, resulting in higher success rates (Wei et
al., 2002). Since the introduction of free tissue transfer, ad-
vances have resulted in success rates of 90 to 99 per cent
among experienced surgeons (Gardiner and Nanchahal,
2010; Kakarala et al., 2012; Brinkman et al., 2013). Despite
this progress, vascular thrombosis still remains one of the
major postoperative complications after free flap microvas-
cular surgery (Godina, 1979). It is associated with higher
morbidity, potential flap loss, higher costs, and increased
length of hospital stay. Total flap failure and even partial
loss may have devastating consequences, although they are
rare (Fig. 1). In those cases, not only the reconstruction has
failed, but then a donor site scar is present — two holes in-
stead of one.
A number of modifiable factors in the perioperative period
have the potential influence to free tissue transfer outcomes.
Long duration of the surgery, with high surgical-anaesthetic
risk, and comorbidities may affect success of the technique
(e.g., hypercoagulability, diabetes mellitus, poor nutritional
status, cardiovascular disease, peripheral vascular disease,
collagen diseases). Moreover, anaesthesia may be an impor-
tant and determining factor due to its role in maintaining
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Microvascular free flap surgery, has become an important part of reconstructive surgery during
the last decades, as it allows closure of various tissue defects and recovery of organs function.
Despite surgical progress resulting in high rates of transferred tissue survival, the risk of pedicle
vessels thrombosis still remains a significant problem. A total of 108 articles from Pubmed and
Science Direct databases published in 2005–2015 were analysed. This review of the literature as-
sessed the influence of patient-dependent risk factors and different perioperative management
strategies on development of microvascular free flap thrombosis. Sufficient evidence for risk as-
sociated with hypercoagulation, advanced age and certain comorbidities was identified. Pres-
ently, rotational thromboelastometry allows early hypercoagulability detection, significantly
changing further patient management. Identification of flap thrombosis promoting surgery-related
aspects is also essential in preoperative settings. Choice of anaesthesia and postoperative anal-
gesia, administration of different types and amounts of fluids, blood products and vasoactive
agents, temperature control are no less important in perioperative anaesthesiological manage-
ment. More attention should be focused on timely preoperative evaluation of patient-dependent
risk factors, which can influence anaesthesiological and surgical tactics during and after micro-
vascular free flap surgery. Perioperative anaesthesiological management strategy continues to be
controversial and therefore it should be performed based on thrombotic risk assessment and pa-
tient individual needs, thus improving flap survival rates and surgical outcome.
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R e v i e w
haemodynamic stability and regional blood flow. Also,
blood flow in the flap can be influenced by regional anaes-
thesia, changes in blood volume, and vasoactive drugs
(Sigurdsson and Thomson, 1995; Adams and Charlton,
2003).
The aim of this review was to collect literature data from
the last decade, which demonstrates the role of preoperative
patient-dependent risk factors and diversity of perioperative
anaesthesiological management strategies affecting the risk
of free flap failure in microvascular surgery.
Surgical phases and direct causes of free flap thrombo-
sis. The majority of thrombosis cases occur within 2–3
postoperative days (Chang et al., 2013); venous thrombosis
is more common than arterial occlusion. The main surgical
phases and causes of thrombosis are common for all micro-
vascular free flap transfer surgery cases. The basic steps of
flap transfer are:
• Flap separation and clamping of blood vessels;
• Cessation of blood flow causing primary ischemia and
initiating anaerobic intracellular metabolism (depending on
surgical time it lasts 60–90 min);
• Reperfusion after the anastomoses are completed and
the clamps are released. Secondary ischemia can occur fol-
lowing attachment, after a free flap has been transferred and
reperfused. Risk of secondary ischemia can be minimised
by optimal anaesthetic technique and appropriate fluid ther-
apy (Quinlan and Lodi, 2009).
Flap vascular thrombosis is one of the major perioperative
complications of microvascular surgery. Numerous factors
may contribute to free flap failure, but direct causes are
(Adams & Charlton, 2003):
• Vasospasm for arterial thrombosis;
• Impairment of venous drainage due to vasospasm and
mechanical compression (e.g., dressings, positioning) for
venous thrombosis;
• Progressive flap oedema caused by excessive use of
crystalloids, excessive hemodilution, prolonged ischemia,
histamine release (e.g., anaesthetics, antibiotics), flap exces-
sive manipulation.
• Generalised vasoconstriction: hypovolemia, hypother-
mia, pain, respiratory alkalosis (e.g., decreased cardiac out-
put).
• Hypotension: hypovolemia, myocardium depressor
drugs (e.g., anaesthetics, Ca2+ channel blockers), vasodila-
tion, heart failure (e.g., ischemia, volume overload, acido-
sis).
• Prolonged ischemia of the flap.
METHODOLOGY OF THE REVIEW
We performed a review of current literature in order to
identify factors negatively influencing microvascular free
flap surgery results, divided into three groups: preopera-
tively identifiable patient dependent risk factors, surgery de-
pendent risk factors, and perioperative anaesthesiological
management strategies. PubMed and Science Direct data-
bases were used. The search was performed using the fol-
lowing algorithm and key terms: (preoperative assessment)
or (perioperative management) or (temperature) or (anaes-
thesia) or (fluids) or (vasopressors) or (vasodilators) or (an-
ticoagulants) and (free flap failure) or (free flap reexplora-
tion) or (free flap thrombosis). A total of 108 English
language articles published in 2005–2015 were selected and
analysed.
PREOPERATIVE PATIENT-DEPENDENT RISK FAC-
TORS
While there have been long-lasting discussions during the
last decade about different aspects of patient perioperative
management, much less effort has been focused on preop-
erative identification of potentially high-risk thrombosis pa-
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Fig. 1. Tissue defect closed with a. radialis free flap before and after microvascular flap thrombosis.
tients. Numerous patient-dependent risk factors can be es-
tablished preoperatively, which negatively influence free
tissue transfer outcome.
Hypercoagulatation. Flap loss most often occurs because
of thrombosis of the microvascular pedicle, which is secon-
dary to technical factors, such as intima damage, vessel
kinking, and technical errors regarding the anastomosis
(Stepanovs et al., 2015). However, even despite appropri-
ate surgical technique and follow-up, flap failures can be
encountered due to systemic influences — acquired or he-
reditary coagulation disorders like a posttraumatic hyperco-
agulable state or resistance to activated protein C (Yu et al.,
2009; Wang et al., 2012). Hypercoagulability is a propen-
sity for inappropriate or pathological thrombus formation.
Approximately 5–10% of the population is estimated to
have a hypercoagulable condition, which frequently is un-
recognised or not detectable by routine tests (Rosendaal,
1999; Kitchens, 2008). Some authors have assessed the use
of rotational thromboelastometry (RTE) for hypercoagula-
bility detection in free flap surgery (Kolbenschlag et al.,
2014; Wikner et al., 2015) (Fig. 2). RTE analysis is based
on an in vitro clotting process. It generates a real-time im-
age of in vitro clot formation, demonstrating the interaction
between plasmatic components of coagulation and cellular
elements. RTE has been used in clinical settings to detect
hypo- or hyper-coagulability, fibrinolysis and clot strength,
mostly for haemorrhagic trauma or bleeding cardiac surgery
patients. In a recent systematic review, RTE has been
shown as an effective tool to evaluate coagulation distur-
Fig. 2. Rotational thromboelastometry (RTE)
test in a patient with hypercoagulability and
thrombotic flap loss.
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bances in septic conditions where the clotting process often
is enhanced despite the presence of a low platelet count
(Müller et al., 2014). In patients undergoing free flap trans-
fer surgery, Kolbenschlag et al. found RTE as a useful tool
for screening coagulation balance and prediction of throm-
botic complication (Fig. 2). However, Wikner et al. could
not confirm these results and recommended RTE only for
assessment of the anticoagulation needs of individual pa-
tients undergoing free flap surgery.
In some cases thrombosis may develop only in the presence
of an additional factor like oral contraception, another sur-
gery, or cancer (De Stefano et al., 1999; Olsson et al., 2001;
Vandenbroucke et al., 2001). Genetic mutations, such as
factor V Leiden (Davison et al., 2009; Khansa et al., 2011),
factor VIII levels (Höijer & Olsson, 2006), AT III muta-
tions, decreased protein C (Handschel et al., 2013) and S
levels, and hyperhomocisteinemia (Labow et al., 2007)
have been demonstrated as possible reasons of free flap fail-
ure in various reconstruction types. Hereditary or acquired
posttraumatic coagulation disorders can lead not only to
more frequent flap thrombosis, but also to worse results in
case of reexploration. Free tissue transfer is still possible,
but the success rate is only 80 per cent, as demonstrated by
a study that investigated a series of 58 flaps (Wang et al.,
2012). Consequently, special attention should be paid to as-
sessment of thrombophilia, and detailed preoperative
evaluation is crucial. Some institutions recommend to
change the surgery plan and to close tissue defect with a pe-
dicle flap instead of free flap due to higher risk of thrombo-
sis (Sezgin et al., 2012).
Advanced age and comorbidities. Chronological age
alone is considered not to be a contraindication for surgery
or a risk factor for postoperative morbidity and flap failure
(Ozkan et al., 2005; Wong et al., 2014). Comorbidities, in-
cluding chronic obstructive pulmonary disease (Fischer et
al., 2013), complications of diabetes (Lee et al., 2014;
Scalia et al., 2007), smoking history (Brands et al., 2010;
Chang, 2006), high American Society of Anesthesiologists
(ASA) status (Coskunfirat et al. 2005), and malnutrition
(Shum et al., 2014), have more negative influence to flap
failure. Smoking should be stopped as much as possible
(Kuri et al. 2005). Advanced age often goes together with
chronic cardiac failure, aortic valve stenosis, and decreased
systolic function. This is well known, since low cardiac in-
dex cannot provide flap perfusion pressure and left ven-
tricular failure guarantees loss of transferred tissue (Adams
and Charlton, 2003). Perhaps patients with significant car-
diac disease should undergo less ambitious surgery, al-
though aesthetically less satisfactory. Peripheral vascular
disease was found to be a statistically significant risk factor
for flap thrombosis in breast reconstruction surgery (Ma-
soomi et al., 2014). Similar results were found by Lee et al.
in diabetic patients with tissue defects of the lower extremi-
ties, and atherosclerotic calcifications were confirmed as
risk factors for flap survival (Lee et al., 2014). No athero-
sclerotic calcifications were seen in the complete healing
group, although they were found in 12 patients in the com-
plication group, and this difference was significant (Lee et
al., 2014).
In contrast, in 10-years follow-up of cases, advanced age
was identified as the only factor for increased risk of subse-
quent flap loss in cases revised due to thrombosis in patients
undergoing lower extremity reconstruction surgery. Other
factors such as cardiovascular disease, diabetes mellitus,
body mass index and history of smoking were not associ-
ated with increased risk of flap thrombosis (Wettstein et
al., 2008).
Preoperative anaemia. Patients undergoing microvascular
reconstruction are often anaemic from a combination of ia-
trogenic haemodilution and acute blood loss. Preoperative
anaemia with haematocrit (Hct) level less than 30% and
haemoglobin (Hb) less than 10 g/dl can significantly impact
free flap morbidity (Hill et al., 2012). However, some stud-
ies have not confirmed these results (Mlodinow et al. 2013).
Haemoglobin and haematocrit levels should be optimised
before surgery (Hb > 10 g/dl, Hct > 30 per cent) (Clark et
al., 2007).
PREOPERATIVE SURGERY DEPENDENT RISK FAC-
TORS
Data from the literature suggest that duration of surgical re-
construction as well as specific defect localisation and tis-
sue flap type may significantly affect survival of free flap.
These aspects should be considered by the surgeon before
intervention, in order to offer an optimal plan for tissue de-
fect closing.
Prolonged operation time. Duration of surgery exceeding
eight hours is likely to occur in head and neck free flap sur-
gery (Wolff et al., 2008; Al-Dam et al., 2014). Longer time
spent in the operation theatre is a significant prognostic fac-
tor for overall medical complications in free flap surgery
(Rosenberg et al., 2009). Additionally, in a study including
639 patients undergoing 778 flaps over a four-year study
period, operative time was identified as an independent risk
factor for free flap failure. After adjusting for other factors,
those whose operative time was equal to or greater than the
75th percentile (625.5 min) were twice as likely to experi-
ence flap failure (Wong et al., 2014).
Defect localisation and type of reconstruction. Additional
risk factors associated with tissue defect localisation and
type of flap (Table 1) are identified in the analysed articles.
Also, some general factors like comorbidities have positive
predictive value only in specific types of surgery.
The most common cause of thrombosis is technical error or
local factor, such as intima trauma, vessel kinking, and
technical anastomotic problems. Nevertheless, preoperative
identification of high thrombotic risk patient- and surgery-
related risks further can affect perioperative anaesthesi-
ological management strategy.
359Proc. Latvian Acad. Sci., Section B, Vol. 70 (2016), No. 6.
PERIOPERATIVE ANAESTHESIOLOGICAL MAN-
AGEMENT STRATEGIES
Basic principles of anaesthesia for free flap transfer should
be maintenance of low viscosity, vasodilatation and good
perfusion pressure.
Perioperative anticoagulation. Data regarding anticoagu-
lation regimens remain inconclusive. Clinical studies com-
paring various anticoagulation regimens have shown
equivalent reduction in the incidence of complications, in-
cluding anastomotic thrombosis and flap loss (Chien et al.,
2005; Lighthall et al., 2013). In a large study on prospective
free tissue transfer, low-molecular-weight heparin
(LMWH) used after the surgery demonstrated similar effec-
tiveness with subcutaneous unfractioned heparin in preven-
tion of postoperative flap thrombosis (Khouri et al., 1998).
A retrospective review comparing LMWH and aspirin ad-
ministered after surgery indicated similar rates of complica-
tions, including haematoma formation and free flap failure,
when compared to other anticoagulation regimens (Ashjian
et al., 2007). Small doses of unfractioned heparin also does
not appear to increase the risk of postoperative haematoma
and haemorrhage (Nahabedian et al., 2008). Interestingly,
intraoperative systemic heparin was found to have no effect
on the incidence of microvascular thrombosis (Chen et al.,
2008). In contrast, postoperative use of subcutaneous un-
fractioned heparin reduces the incidence of postoperative
flap thrombosis significantly. In summary, various antico-
agulation regimens tend to show equivalent reduction in the
incidence of complications. Aspirin orally and heparin sub-
cutaneously alone or in combination can be recommended
for postoperative antithrombotic management.
Anaesthesia and choice of anaesthetics. Most authors sug-
gest balanced general anaesthesia as an optimal method dur-
ing prolonged free flap procedures (Hagau and Longrois,
2009). Earlier publications suggest that isoflurane has the
advantage over other inhalation agents and propofol due to
producing vasodilation with minimal cardiac depression.
However, recent studies offer sevoflurane as a better agent
because of its beneficial effects on microcirculation, reduc-
ing plasma leakage into interstitial space, therefore reducing
flap oedema (Bruegger et al., 2002). Some papers suggest
that it may have a protective effect on endothelial cells
against ischemia-reperfusion injury (Lucchinetti et al.,
2007; Annecke et al., 2010). Regarding regional anaesthesia
methods, older studies demonstrated free flap “steal phe-
nomena” due to inability to dilate transplanted vessels in the
sympathetically denervated recipient zone after regional
block. In contrast, studies conducted in the last decade sup-
port the idea of supplemental regional anaesthesia for digit
replantation and lower extremity free flaps (Kurt et al.,
2005; Su et al., 2005; Bozkurt et al., 2010; Cayci et al.,
2010).
Perioperative analgesia. Regional anaesthesia may be
beneficial, considering necessity to ensure perioperative an-
algesia, especially for the pain site. Conflicting data have
been reported about epidural analgesia. After epidural
blockade, the “steal phenomena” has been revealed as well.
As shown by authors in an older report, microcirculatory
blood flow was markedly decreased in lower extremity free
flaps by redistributing it away from the flap to normal intact
tissues, as measured by multichannel laser Doppler flow-
metry after epidural blockade (Erni et al., 1999). Some
authors argue that reduction of microcirculatory blood flow
can be explained by effect of the centroaxial blockade on
cardiac output and mean arterial pressure. However, recent
papers suggest that use of epidural analgesia should be
beneficial. Concerning peripheral nerve blocks, several
clinical studies have demonstrated that peripheral nerve
blocks reduce vasospasm and improve perfusion of re-
planted or revascularised digits. Nonsteroidal anti-inflam-
matory drugs should be avoided, because of the risk of pe-
rioperative bleeding and hematoma formation. On the other
hand, ketorolac reduces thrombotic complications in lower
extremity free flaps (Lee et al., 2012).
Fluid administration. Appropriate blood flow and oxygen
delivery to the free flap have to be ensured to reduce pe-
rioperative complications. Hyperdynamic circulation with
high cardiac output, pulse pressure, and peripheral vasodila-
tion is required to maintain perfusion pressure in trans-
planted flaps. Traditionally, hypervolemic haemodilution
has been used during anaesthesia for this type of surgery.
Because free flaps are subjected to interstitial oedema, ex-
cessive fluid administration can be deleterious (Shetty et al.,
2009). Many studies have demonstrated correlation between
high volumes of perioperative crystalloid infusions and flap
as well as overall complications (Patel et al., 2010; Chap-
pell et al., 2008). In a retrospective study of 104 free trans-
verse rectus abdominis myocutaneous flaps, patients with
thrombosis of the flap anastomosis received significantly
higher fluid volumes during the surgery (Booi, 2011).
Moreover, a review of 354 breast reconstructions showed
that crystalloid infusion rate is a significant predictor of
complications (Zhong et al., 2011). Only a few studies have
T a b l e 1





Head, neck History of radical concurrent
chemoradiotherapy (Yoshimoto, Kawabata, Mitani,
2010)
Proximal defect localisation (Gerressen et al., 2013)
Acute malnutrition (Shum et al., 2014)
Breast Reconstruction with free superficial inferior
epigastric artery (SIEA) flap (Masoomi et al., 2014)
Lower extremity History of angioplasties in the extremity (Oh et al.,
2013)
Using immunosuppressive agents after kidney trans-
plant in diabetic patients (Oh et al., 2013)
Tissue defect localisation in the distal tibia region
(Fischer et al., 2013)
Reconstruction with rectus abdominis flap (Fischer et
al., 2013)
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examined the role of colloids to replace intraoperative blood
loss (Arellano et al., 2005), without giving any negative in-
formation of modern hydroxyethyl starches. Therefore, pa-
tients should receive limited amounts of crystalloids only
for basic physiological needs to avoid causing flap oedema.
Synthetic colloids should be administered to replace in-
traoperative blood loss, and blood products given to main-
tain haematocrit (Karakida et al., 2010). The ideal rate of
crystalloid infusions is 3.5 to 6.0 ml/kg per hour in a 24-
hour perioperative period (Motakef et al., 2015). In contrast
with older studies that suggested to use dextran due to its
rheological properties, a review of 1351 free flaps showed
that dextran in high-risk oncological patients significantly
increased the rate of flap failure without showing any influ-
ence on flap survival, compared to no antithrombotic ther-
apy (Riva et al., 2012). Benefit of dextran infusions in
terms of flap survival has not been clinically demonstrated
yet (Pohlenz et al., 2007). Furthermore, dextran administra-
tion is associated with higher incidence of systemic compli-
cations (Disa et al., 2003).
Transfusion of blood products. Preoperative anaemia is
associated with an increased length of hospital stay and is a
significant predictor of flap failure and thrombosis. On the
other hand, perioperative transfusions have negative influ-
ence on patient morbidity, as shown in patients undergoing
cardiac surgery (Zellans et al., 2014) and reconstructive free
flap surgery (Szakmany et al., 2006).
Blood loss can be remarkable during extensive and long
microvascular surgery. The loss can be very slow, but
long-lasting, and therefore assessment can be false and the
real value of haemoglobin can be revealed only in later
postoperative days. Red blood cells transfusions should be
performed to maintain Hb and Hct at appropriate levels for
adequate perfusion and tissue oxygen delivery. However,
transfusions have to be performed with caution and a more
restrictive transfusion strategy should be applied (Kozek-
Langenecker et al., 2013), considering association between
amount of intraoperative blood products transfused and
higher rates of complications, requirements of postoperative
transfusions and reoperations (Kim et al., 2014). In addi-
tion, perioperative transfusions were found to have negative
influence on morbidity and mortality in free flap reconstruc-
tion surgery, including cancer recurrence (Kao et al., 2010)
and promotion of wound infections (Liu et al., 2007), due to
their immunomodulatory effect (Vamvakas and Blajchman,
2007). It is recommended to use a restrictive strategy, and
reserve transfusions for clinically symptomatic patients or
those with haemoglobin level less than 7 g/dl.
Vasoactive drugs. Although vasodilators are widely used
for topical application due to their favourable effect on flap
flow, usage of vasopressors is more conservative to balance
the risk of vasoconstriction and the potential benefit of in-
creased mean arterial pressure, which subsequently im-
proves perfusion pressure across the free flap. Administra-
tion of vasopressors before division of the free flap may
affect the size of the perforator and thus the technical diffi-
culty of the dissection. Unlike as in older studies, in recent
studies show that administration of vasopressors following
flap division does not impact flap outcomes (Chen et al.,
2010; Monroe et al., 2010; 2011). Prospective studies com-
paring effect of epinephrine, norepinephrine, dobutamine,
and dopexamine demonstrated that both dobutamine and
norepinephrine improved blood flow in free flap skin, with
norepinephrine yielding the greatest improvement (Eley et
al., 2012; 2013). After division of the flap, if a vasopressor
is needed, it should be tailored for maintaining blood pres-
sure and flap flow, despite widespread prejudice and infor-
mation given in older studies (Louer et al., 2013), helping
to avoid excessive fluid administration and interstitial oe-
dema. Preferable agents are norepinephrine and dobuta-
mine. In contrast, dopexamine and epinephrine can decrease
flap flow. Beta-blockers should be avoided as they can
cause relative vasoconstriction in peripheral tissues.
Temperature management. Conflicting data exists regard-
ing intraoperative temperature control. Some studies
(Thomson et al., 2009; Liu et al., 2011; ) report correlation
of mild hypothermia with lower rates of flap thrombosis.
However, the majority of reports on humans show that hy-
pothermia is associated with perioperative complications. A
retrospective study of 156 free flaps demonstrated correla-
tion between intraoperative hypothermia (average core tem-
perature, < 35.0 °C; minimum core temperature, < 34.5 °C)
and recipient-site infections (Hill et al., 2015). Intraoper-
ative hypothermia (minimum core temperature, < 35.0 °C)
also is correlated with overall perioperative complications
(Sumer et al., 2009). Maintenance of normothermia may be
difficult with a large areas exposed for prolonged periods
during surgery, predisposing patients to hypothermia. In ad-
dition, anaesthesia changes the thermoregulatory mecha-
nisms. Central and peripheral temperature must be moni-
tored and the ideal difference between them should be less
than 2 °C (Hagau and Longrois, 2009). If preventative mea-
sures are not in place, hypothermia may occur in as many as
50 to 90 per cent of surgical patients (Young and Watson,
2006). Since the majority of studies found that hypothermia
is associated with perioperative complications, it is recom-
mended to maintain ambient room temperature at approxi-
mately 24 °C before patients are in the operating room, and
other preventative efforts should be made to avoid hypo-
thermia (Gardiner and Nanchahal, 2010).
CONCLUSIONS
More attention should be focused on timely preoperative
evaluation of patient-dependent risk factors, which can in-
fluence anaesthesiological and surgical tactics during and
after microvascular free flap surgery. Perioperative
anaesthesiological management strategy continues to be
controversial therefore it should be performed based on
thrombotic risk assessment and patient individual needs,
thus improving flap survival rates and surgical outcome.
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BRÎVO LÇVERU TROMBOÞU RISKU IETEKMÇJOÐIE FAKTORI MIKROVASKULÂRAJÂ ÍIRURÌIJÂ
Mikrovaskulârâ brîvo lçveru íirurìija pçdçjâs dekâdes laikâ ir kïuvusi par nozîmîgu rekonstruktîvâs íirurìijas daïu, ïaujot slçgt defektus
daþâdos audos, atjaunojot normâlu orgânu funkciju. Neraugoties uz ievçrojamo progresu mikrovaskulârajâ íirurìijâ, kas rezultçjas ar
pârvietoto audu augstu izdzîvoðanas procentu, lçvera kâjiòas asinsvadu trombozes risks joprojâm paliek nozîmîga problçma. Literatûras
pârskatâ analizçtas 108 publikâcijas no Pubmed un Science Direct datu bâzçm par 2005.–2015. gadu periodu; izvçrtçta no pacienta atkarîgo
riska faktoru un daþâdu perioperatîvâs aprûpes aspektu ietekme uz brîvâ lçvera asinsvadu trombozi. Identificçta no pacienta atkarîgo riska
faktoru — hiperkoagulâcijas, vecuma un blakusslimîbu — ietekme. Mûsdienâs rotâcijas trombelastometrija ïauj agrîni atklât
hiperkoagulâciju, nozîmîgi mainot turpmâko pacienta ârstçðanas stratçìiju. Pirmsoperâcijas periodâ ir bûtiska arî ar íirurìiju saistîto lçvera
trombozi veicinoðo faktoru identifikâcija. Anestçzijas un perioperatîvâs analgçzijas izvçle, daþâdu ðíidrumu veidu un daudzumu, asins
produktu, vazoaktîvo medikamentu nozîmçðana, temperatûras kontrole ir ne mazâk svarîgi aspekti ârstçðanas taktikas izvçlç perioperatîvajâ
periodâ. Pirmsoperâcijas novçrtçðanâ vairâk uzmanîbas vajadzçtu pievçrst savlaicîgai no pacienta atkarîgo faktoru izvçrtçðanai, kas var
ietekmçt anestezioloìisko un íirurìisko taktiku mikrovaskulârajâ brîvo lçveru íirurìijâ. Perioperatîvâ anestezioloìiskâ aprûpes stratçìija
joprojâm ir pretrunîga, tai jâtiek îstenotai, balstoties uz tromboþu risku izvçrtçðanu un pacientu individuâlajâm prasîbâm, uzlabojot lçvera
izdzîvoðanu un íirurìisko rezultâtu.
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